 | • レポートコード：MRC2012A2586 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ダルベポエチンアルファの世界市場を広く調査・分析し、今後の市場展望をまとめております。ダルベポエチンアルファの種類別市場規模（エポゲン、プロクリット、アラネスプ、その他）、用途別市場規模（慢性腎臓病患者、がん患者、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen、Novartis、Johnson & Johnson、Kyowa Hakko Kirin、3SBio、 ・地域別グローバル市場分析 2015年-2020年 ・ダルベポエチンアルファの北米市場（アメリカ、カナダ、メキシコ） ・ダルベポエチンアルファのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ダルベポエチンアルファのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ダルベポエチンアルファの南米市場（ブラジル、アルゼンチン） ・ダルベポエチンアルファの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：エポゲン、プロクリット、アラネスプ、その他 ・用途別分析：慢性腎臓病患者、がん患者、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Darbepoetin Alfa market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Darbepoetin Alfa market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -3.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 4732.4 million by 2025, from USD 5380.5 million in 2019.
Market segmentation
Darbepoetin Alfa market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Darbepoetin Alfa market has been segmented into
Epogen
Procrit
Aranesp
Others
By Application, Darbepoetin Alfa has been segmented into:
Patients with Chronic Kidney Disease
Patients with Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Darbepoetin Alfa market presented in the report. This section sheds light on the sales growth of different regional and country-level Darbepoetin Alfa markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Darbepoetin Alfa market.
The report offers in-depth assessment of the growth and other aspects of the Darbepoetin Alfa market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Darbepoetin Alfa Market Share Analysis
Darbepoetin Alfa competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Darbepoetin Alfa sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Darbepoetin Alfa sales, revenue and market share for each player covered in this report.
The major players covered in Darbepoetin Alfa are:
Amgen
Novartis
Johnson & Johnson
Kyowa Hakko Kirin
3SBio
Among other players domestic and global, Darbepoetin Alfa market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Darbepoetin Alfa product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Darbepoetin Alfa, with price, sales, revenue and global market share of Darbepoetin Alfa in 2018 and 2019.
Chapter 3, the Darbepoetin Alfa competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Darbepoetin Alfa breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Darbepoetin Alfa market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Darbepoetin Alfa sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Darbepoetin Alfa Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Darbepoetin Alfa Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Epogen
1.2.3 Procrit
1.2.4 Aranesp
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Darbepoetin Alfa Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Patients with Chronic Kidney Disease
1.3.3 Patients with Cancer
1.3.4 Others
1.4 Overview of Global Darbepoetin Alfa Market
1.4.1 Global Darbepoetin Alfa Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Kyowa Hakko Kirin
2.4.1 Kyowa Hakko Kirin Details
2.4.2 Kyowa Hakko Kirin Major Business
2.4.3 Kyowa Hakko Kirin SWOT Analysis
2.4.4 Kyowa Hakko Kirin Product and Services
2.4.5 Kyowa Hakko Kirin Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 3SBio
2.5.1 3SBio Details
2.5.2 3SBio Major Business
2.5.3 3SBio SWOT Analysis
2.5.4 3SBio Product and Services
2.5.5 3SBio Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Darbepoetin Alfa Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Darbepoetin Alfa Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Darbepoetin Alfa Manufacturer Market Share in 2019
3.3.2 Top 6 Darbepoetin Alfa Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Darbepoetin Alfa Sales, Revenue and Market Share by Regions
4.1.1 Global Darbepoetin Alfa Sales and Market Share by Regions (2015-2020)
4.1.2 Global Darbepoetin Alfa Revenue and Market Share by Regions (2015-2020)
4.2 North America Darbepoetin Alfa Sales and Growth Rate (2015-2020)
4.3 Europe Darbepoetin Alfa Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Darbepoetin Alfa Sales and Growth Rate (2015-2020)
4.5 South America Darbepoetin Alfa Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Darbepoetin Alfa Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Darbepoetin Alfa Sales, Revenue and Market Share by Country
5.1.1 North America Darbepoetin Alfa Sales and Market Share by Country (2015-2020)
5.1.2 North America Darbepoetin Alfa Revenue and Market Share by Country (2015-2020)
5.2 United States Darbepoetin Alfa Sales and Growth Rate (2015-2020)
5.3 Canada Darbepoetin Alfa Sales and Growth Rate (2015-2020)
5.4 Mexico Darbepoetin Alfa Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Darbepoetin Alfa Sales, Revenue and Market Share by Country
6.1.1 Europe Darbepoetin Alfa Sales and Market Share by Country (2015-2020)
6.1.2 Europe Darbepoetin Alfa Revenue and Market Share by Country (2015-2020)
6.2 Germany Darbepoetin Alfa Sales and Growth Rate (2015-2020)
6.3 UK Darbepoetin Alfa Sales and Growth Rate (2015-2020)
6.4 France Darbepoetin Alfa Sales and Growth Rate (2015-2020)
6.5 Russia Darbepoetin Alfa Sales and Growth Rate (2015-2020)
6.6 Italy Darbepoetin Alfa Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Darbepoetin Alfa Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Darbepoetin Alfa Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Darbepoetin Alfa Revenue and Market Share by Regions (2015-2020)
7.2 China Darbepoetin Alfa Sales and Growth Rate (2015-2020)
7.3 Japan Darbepoetin Alfa Sales and Growth Rate (2015-2020)
7.4 Korea Darbepoetin Alfa Sales and Growth Rate (2015-2020)
7.5 India Darbepoetin Alfa Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Darbepoetin Alfa Sales and Growth Rate (2015-2020)
7.7 Australia Darbepoetin Alfa Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Darbepoetin Alfa Sales, Revenue and Market Share by Country
8.1.1 South America Darbepoetin Alfa Sales and Market Share by Country (2015-2020)
8.1.2 South America Darbepoetin Alfa Revenue and Market Share by Country (2015-2020)
8.2 Brazil Darbepoetin Alfa Sales and Growth Rate (2015-2020)
8.3 Argentina Darbepoetin Alfa Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Darbepoetin Alfa Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Darbepoetin Alfa Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Darbepoetin Alfa Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Darbepoetin Alfa Sales and Growth Rate (2015-2020)
9.3 Turkey Darbepoetin Alfa Sales and Growth Rate (2015-2020)
9.4 Egypt Darbepoetin Alfa Sales and Growth Rate (2015-2020)
9.5 South Africa Darbepoetin Alfa Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Darbepoetin Alfa Sales and Market Share by Type (2015-2020)
10.2 Global Darbepoetin Alfa Revenue and Market Share by Type (2015-2020)
10.3 Global Darbepoetin Alfa Price by Type (2015-2020)
11 Global Darbepoetin Alfa Market Segment by Application
11.1 Global Darbepoetin Alfa Sales Market Share by Application (2015-2020)
11.2 Global Darbepoetin Alfa Revenue Market Share by Application (2015-2020)
11.3 Global Darbepoetin Alfa Price by Application (2015-2020)
12 Market Forecast
12.1 Global Darbepoetin Alfa Sales, Revenue and Growth Rate (2021-2025)
12.2 Darbepoetin Alfa Market Forecast by Regions (2021-2025)
12.2.1 North America Darbepoetin Alfa Market Forecast (2021-2025)
12.2.2 Europe Darbepoetin Alfa Market Forecast (2021-2025)
12.2.3 Asia-Pacific Darbepoetin Alfa Market Forecast (2021-2025)
12.2.4 South America Darbepoetin Alfa Market Forecast (2021-2025)
12.2.5 Middle East & Africa Darbepoetin Alfa Market Forecast (2021-2025)
12.3 Darbepoetin Alfa Market Forecast by Type (2021-2025)
12.3.1 Global Darbepoetin Alfa Sales Forecast by Type (2021-2025)
12.3.2 Global Darbepoetin Alfa Market Share Forecast by Type (2021-2025)
12.4 Darbepoetin Alfa Market Forecast by Application (2021-2025)
12.4.1 Global Darbepoetin Alfa Sales Forecast by Application (2021-2025)
12.4.2 Global Darbepoetin Alfa Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Darbepoetin Alfa Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Darbepoetin Alfa by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Darbepoetin Alfa Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Darbepoetin Alfa Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Darbepoetin Alfa Major Business
Table 10. Amgen Darbepoetin Alfa Total Revenue (USD Million) (2018-2019)
Table 11. Amgen SWOT Analysis
Table 12. Amgen Darbepoetin Alfa Product and Services
Table 13. Amgen Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Novartis Basic Information, Manufacturing Base and Competitors
Table 15. Novartis Darbepoetin Alfa Major Business
Table 16. Novartis Darbepoetin Alfa Total Revenue (USD Million) (2018-2019)
Table 17. Novartis SWOT Analysis
Table 18. Novartis Darbepoetin Alfa Product and Services
Table 19. Novartis Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 21. Johnson & Johnson Darbepoetin Alfa Major Business
Table 22. Johnson & Johnson Darbepoetin Alfa Total Revenue (USD Million) (2018-2019)
Table 23. Johnson & Johnson SWOT Analysis
Table 24. Johnson & Johnson Darbepoetin Alfa Product and Services
Table 25. Johnson & Johnson Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 27. Kyowa Hakko Kirin Darbepoetin Alfa Major Business
Table 28. Kyowa Hakko Kirin Darbepoetin Alfa Total Revenue (USD Million) (2018-2019)
Table 29. Kyowa Hakko Kirin SWOT Analysis
Table 30. Kyowa Hakko Kirin Darbepoetin Alfa Product and Services
Table 31. Kyowa Hakko Kirin Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. 3SBio Basic Information, Manufacturing Base and Competitors
Table 33. 3SBio Darbepoetin Alfa Major Business
Table 34. 3SBio Darbepoetin Alfa Total Revenue (USD Million) (2018-2019)
Table 35. 3SBio SWOT Analysis
Table 36. 3SBio Darbepoetin Alfa Product and Services
Table 37. 3SBio Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Global Darbepoetin Alfa Sales by Manufacturer (2018-2019) (M Units)
Table 39. Global Darbepoetin Alfa Revenue by Manufacturer (2018-2019) (USD Million)
Table 40. Global Darbepoetin Alfa Sales by Regions (2015-2020) (M Units)
Table 41. Global Darbepoetin Alfa Sales Market Share by Regions (2015-2020)
Table 42. Global Darbepoetin Alfa Revenue by Regions (2015-2020) (USD Million)
Table 43. North America Darbepoetin Alfa Sales by Countries (2015-2020) (M Units)
Table 44. North America Darbepoetin Alfa Sales Market Share by Countries (2015-2020)
Table 45. North America Darbepoetin Alfa Revenue by Countries (2015-2020) (USD Million)
Table 46. North America Darbepoetin Alfa Revenue Market Share by Countries (2015-2020)
Table 47. Europe Darbepoetin Alfa Sales by Countries (2015-2020) (M Units)
Table 48. Europe Darbepoetin Alfa Sales Market Share by Countries (2015-2020)
Table 49. Europe Darbepoetin Alfa Revenue by Countries (2015-2020) (USD Million)
Table 50. Asia-Pacific Darbepoetin Alfa Sales by Regions (2015-2020) (M Units)
Table 51. Asia-Pacific Darbepoetin Alfa Sales Market Share by Regions (2015-2020)
Table 52. Asia-Pacific Darbepoetin Alfa Revenue by Regions (2015-2020) (USD Million)
Table 53. South America Darbepoetin Alfa Sales by Countries (2015-2020) (M Units)
Table 54. South America Darbepoetin Alfa Sales Market Share by Countries (2015-2020)
Table 55. South America Darbepoetin Alfa Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Darbepoetin Alfa Revenue Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Darbepoetin Alfa Sales by Countries (2015-2020) (M Units)
Table 58. Middle East & Africa Darbepoetin Alfa Sales Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Darbepoetin Alfa Revenue by Countries (2015-2020) (USD Million)
Table 60. Middle East & Africa Darbepoetin Alfa Revenue Market Share by Countries (2015-2020)
Table 61. Global Darbepoetin Alfa Sales by Type (2015-2020) (M Units)
Table 62. Global Darbepoetin Alfa Sales Share by Type (2015-2020)
Table 63. Global Darbepoetin Alfa Revenue by Type (2015-2020) (USD Million)
Table 64. Global Darbepoetin Alfa Revenue Share by Type (2015-2020)
Table 65. Global Darbepoetin Alfa Sales by Application (2015-2020) (M Units)
Table 66. Global Darbepoetin Alfa Sales Share by Application (2015-2020)
Table 67. Global Darbepoetin Alfa Sales Forecast by Regions (2021-2025) (M Units)
Table 68. Global Darbepoetin Alfa Market Share Forecast by Regions (2021-2025)
Table 69. Global Darbepoetin Alfa Sales Forecast by Type (2021-2025) (M Units)
Table 70. Global Darbepoetin Alfa Market Share Forecast by Type (2021-2025)
Table 71. Global Darbepoetin Alfa Sales Forecast by Application (2021-2025)
Table 72. Global Darbepoetin Alfa Market Share Forecast by Application (2021-2025)
Table 73. Direct Channel Pros & Cons
Table 74. Indirect Channel Pros & Cons
Table 75. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Darbepoetin Alfa Picture
Figure 2. Global Sales Market Share of Darbepoetin Alfa by Type in 2019
Figure 3. Epogen Picture
Figure 4. Procrit Picture
Figure 5. Aranesp Picture
Figure 6. Others Picture
Figure 7. Darbepoetin Alfa Sales Market Share by Application in 2019
Figure 8. Patients with Chronic Kidney Disease Picture
Figure 9. Patients with Cancer Picture
Figure 10. Others Picture
Figure 11. Global Darbepoetin Alfa Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Darbepoetin Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Darbepoetin Alfa Sales Market Share by Manufacturer in 2019
Figure 32. Global Darbepoetin Alfa Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Darbepoetin Alfa Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Darbepoetin Alfa Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 37. Global Darbepoetin Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Darbepoetin Alfa Revenue Market Share by Regions (2015-2020)
Figure 39. Global Darbepoetin Alfa Revenue Market Share by Regions in 2018
Figure 40. North America Darbepoetin Alfa Sales and Growth Rate (2015-2020)
Figure 41. Europe Darbepoetin Alfa Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Darbepoetin Alfa Sales and Growth Rate (2015-2020)
Figure 43. South America Darbepoetin Alfa Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Darbepoetin Alfa Sales and Growth Rate (2015-2020)
Figure 45. North America Darbepoetin Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Darbepoetin Alfa Sales Market Share by Countries (2015-2020)
Figure 47. North America Darbepoetin Alfa Sales Market Share by Countries in 2018
Figure 48. North America Darbepoetin Alfa Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Darbepoetin Alfa Revenue Market Share by Countries in 2018
Figure 50. United States Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 51. Canada Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 52. Mexico Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 53. Europe Darbepoetin Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Darbepoetin Alfa Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Darbepoetin Alfa Revenue Market Share by Countries in 2019
Figure 56. Germany Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 57. UK Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 58. France Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 59. Russia Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 60. Italy Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 61. Asia-Pacific Darbepoetin Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Darbepoetin Alfa Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Darbepoetin Alfa Revenue Market Share by Regions 2019
Figure 64. China Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 65. Japan Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 66. Korea Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 67. India Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 68. Southeast Asia Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 69. South America Darbepoetin Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Darbepoetin Alfa Sales Market Share by Countries in 2019
Figure 71. South America Darbepoetin Alfa Revenue Market Share by Countries in 2019
Figure 72. Brazil Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 73. Argentina Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 74. Middle East and Africa Darbepoetin Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Darbepoetin Alfa Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Darbepoetin Alfa Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Darbepoetin Alfa Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 79. Egypt Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 80. Turkey Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 81. South Africa Darbepoetin Alfa Sales and Growth Rate (2015-2020) (M Units)
Figure 82. Global Darbepoetin Alfa Sales and Growth Rate (2021-2025) (M Units)
Figure 83. Global Darbepoetin Alfa Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Darbepoetin Alfa Market Forecast (2021-2025) (M Units)
Figure 85. Europe Sales Darbepoetin Alfa Market Forecast (2021-2025) (M Units)
Figure 86. Asia-Pacific Sales Darbepoetin Alfa Market Forecast (2021-2025) (M Units)
Figure 87. South America Sales Darbepoetin Alfa Market Forecast (2021-2025) (M Units)
Figure 88. Middle East & Africa Sales Darbepoetin Alfa Market Forecast (2021-2025) (M Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
慢性腎臓病（CKD）の世界市場（～2026年） Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Kidney Disease (CKD) Scope and Market Size Chroni…- エリスロポエチン（EPO）の世界市場（～2026年） Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of Erythropoietin (EPO) Drugs market. According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million peop…
- エリスロポエチン治療薬の世界市場（～2026年） Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule. The retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of …
- エリスロポエチン（EPO）治療薬の世界市場（～2026年） EPO is a naturally occurring hormone produced by cells in the kidneys that regulate the production of red blood cells in bone marrow. Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO-stimulating agents as these diseas…
- チオアミドの世界市場（～2026年） A Thioamide is a functional group with the general structure R–CS–NR′R″, where R, R′, and R″ are organic groups. Thioamides are analogous to amides but they exhibit greater multiple bond character along the C-N bond, resulting in a larger rotational barrier. One of the best-known thioamides is thioa…